Amneal Pharmaceuticals (AMRX) FCF Payout Ratio (2017 - 2018)
Amneal Pharmaceuticals (AMRX) recorded quarterly FCF Payout Ratio of 0.0 in Q4 2018, up 100.0% quarter-over-quarter from 1.32 in Q2 2018, and up 100.0% on a YoY basis from 0.0 in Q4 2017.
Amneal Pharmaceuticals (AMRX) FCF Payout Ratio (2017 - 2018) Analysis & Trends
Amneal Pharmaceuticals' FCF Payout Ratio history runs 2 years deep, the most recent figure standing at 0.0 for Q4 2018.
- In Q4 2018, FCF Payout Ratio rose 100.0% year-over-year to 0.0; the TTM figure through Sep 2019 stood at 0.0 (up 100.0% YoY), while the FY2018 annual figure was 1.09, down 59.32% from the prior year.
- FCF Payout Ratio was 0.0 for Q4 2018 at Amneal Pharmaceuticals, up from 1.32 in the prior quarter.
- In the past five years, FCF Payout Ratio ranged from a high of 3.98 in Q1 2018 to a low of 1.32 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 0.77 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Amneal Pharmaceuticals | 4.34 Bn | 4.33 Bn | 320.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 0.00 |
| Jun 30, 2018 | -1.32 |
| Mar 31, 2018 | 3.98 |
| Dec 31, 2017 | -0.81 |
| Sep 30, 2017 | 1.03 |